Stay updated with breaking news from Azenta. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Azenta (NASDAQ:AZTA – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research note issued on Monday, Zacks.com reports. According to Zacks, “Azenta Inc. is a provider of life sciences solutions. The company provides reliable cold-chain sample management solutions and genomic services across areas such as […]
Azenta, Inc. (NASDAQ:AZTA – Get Rating) – Analysts at B. Riley cut their Q3 2022 earnings per share (EPS) estimates for shares of Azenta in a research note issued on Tuesday, May 17th. B. Riley analyst Y. Zhi now expects that the company will post earnings of $0.07 per share for the quarter, down from […]
/PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the UBS Global Healthcare Conference in New York, on...
Azenta (NASDAQ:AZTA – Get Rating) updated its third quarter earnings guidance on Monday. The company provided earnings per share (EPS) guidance of $0.09-0.17 for the period, compared to the consensus estimate of $0.18. The company issued revenue guidance of $140-150 million, compared to the consensus revenue estimate of $150.40 million.Azenta also updated its Q3 2022 […]
/PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today reported preliminary financial results for the second quarter ended March 31, 2022. Summary of Preliminary...